Back to calendar
Keros Therapeutics, Inc. (KROS) Earnings
KROS reports earnings on Wednesday, August 12, 2026
earnings report
August 12, 2026 · Before Market Open
Est. EPS: $-1.34
Actual EPS: $-1.21
EPS surprise: -18.30%
Company overview
Market Cap$209.2M
PriceUSD 10.57
EPS (TTM)-3.01
52-week high22.55
52-week low9.69
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees78